About Board Scan

BoardEx intelligence, delivered daily with market context.

BoardEx is the institutional-grade director database used by the world's top PE firms, asset managers, and governance research teams. Board Scan delivers the BoardEx appointment feed as a daily alert service, enriched with CRSP 30-day market reactions and 13F institutional co-movement signals so you can act on board changes before the market fully prices them in.

5,500+ BoardEx Companies
75,000+ Director Records
Daily BoardEx Data Refresh
CRSP + 13F Market Enrichment Stack

Institutional data, delivered as a daily alert service

BoardEx maintains the most comprehensive director database in institutional finance. Board Scan licenses BoardEx through Wharton Research Data Services (WRDS) and transforms the raw feed into a daily alert service accessible at $199/mo instead of $18,000+ per year.

Each board appointment from BoardEx is automatically enriched with a CRSP 30-day cumulative return, quantifying how markets priced the director change from the effective date. We add 13F institutional co-movement to flag whether large funds increased positions alongside the appointment.

The result is institutional-quality board intelligence at 1/100th the cost, updated daily, with the market signals built in.

Data Pipeline
01
BoardEx FeedDaily director appointment and departure records from BoardEx via WRDS
02
Record ProcessingAppointment records parsed, deduped, and structured with seniority classification
03
CRSP Enrichment30-day cumulative return from CRSP daily files added per appointment
04
13F SignalInstitutional accumulation flag from 13F filings ($100M+ threshold)
05
Alert DeliveryEmail, API, webhook, and RSS within 24 hours of BoardEx daily refresh

Methodology at a glance

Board Scan's enrichment pipeline layers two market signals onto each BoardEx director appointment. Here is how each stage works.

Stage 01

BoardEx Ingestion

We pull the BoardEx director feed daily via WRDS. Each record includes the director name, company, appointment date, role, seniority tier (Senior Executive, Independent, PE, Academic), and prior board history.

Stage 02

CRSP Enrichment

Each new appointment triggers a CRSP lookup. We compute the 30-day cumulative abnormal return from the appointment effective date using CRSP daily files. This quantifies how equity markets priced the director change in the weeks after announcement.

Stage 03

13F Signal Generation

We cross-reference each appointment against 13F institutional filings. If the company sees net institutional accumulation of 1%+ in the quarter following the appointment, we flag the alert with a co-movement signal. Large-fund endorsement of the board change is a meaningful governance signal.

Stage 04

Alert Dispatch

Enriched alerts are structured with all three data layers: BoardEx director record, CRSP return window, and 13F signal. Alerts are dispatched via email, API, webhook, and RSS within 24 hours of the daily BoardEx refresh.

How we think about data quality

Governance data errors have downstream consequences. We hold ourselves to four principles.

Source-first

Every director record traces to a specific BoardEx record ID via WRDS. Market enrichment sources are cited (CRSP permno, 13F filer CIK) with each alert. Nothing is synthesized without a primary data trail.

Transparent uncertainty

When BoardEx records have low-confidence seniority classifications or missing effective dates, we surface this in the alert rather than presenting incomplete data as authoritative.

Accuracy over speed

The daily BoardEx refresh takes priority over speed. We complete full CRSP and 13F enrichment before dispatching alerts. You get complete signals, not partial ones.

Customer corrections respected

When a subscriber reports a data error, we investigate at the filing level, correct the record in our database, and notify other affected subscribers of the update.

Start with 14 days free

No credit card required. Access the full Professional plan and see how Board Scan fits your workflow before you commit.

Start Free Trial

Questions? Email [email protected]